ASHLAND INC. 8-K

What Happened Ashland Inc. announced on July 27–28, 2026 that it appointed Peter Thomas and Allen Spizzo as independent directors, effective immediately, with initial terms expiring at the Company’s 2027 annual meeting. The Board now has eleven members (ten independent) and has decided to reduce the Board size to ten effective immediately prior to the opening of the polls at the 2027 Annual Meeting. Ashland also entered into a Cooperation Agreement with Ancora Holdings Group, LLC and other members of an Investor Group related to these appointments and formed a five-member Capital Allocation Advisory Committee.

Key Details

• Appointments effective July 27, 2026; initial terms run through the 2027 annual meeting; both are expected to be nominees at the 2027 meeting.
• Advisory Committee membership: Bertrand Loy, Susan L. Main, Allen Spizzo, Peter Thomas and Scott A. Tozier (Chair: Tozier; Vice Chair: Thomas). CEO/Board Chair Guillermo Novo is a non-voting member.
• Cooperation Agreement requires the Investor Group to abide by voting commitments, customary standstill and non-disparagement provisions through a Standstill Period that generally ends either 30 days before the 2028 nomination deadline or 110 days before the first anniversary of the 2027 meeting (with potential extension tied to renomination through 2029).
• If a New Director leaves during the Standstill Period and the Investor Group still beneficially owns at least 1.5% of Ashland’s common stock, the Investor Group may propose a replacement, subject to Board and Governance & Nominating Committee approval. New Directors will receive the Company’s standard non-employee director compensation, including prorated restricted stock units through January 2027 awards.

Why It Matters These changes add two industry-experienced, independent directors and create a focused advisory committee on capital allocation—moves that directly affect board oversight and strategic decision-making. The Cooperation Agreement with Ancora establishes governance commitments and a standstill that could limit activist actions for a defined period, and includes a mechanism for the Investor Group to propose replacements if needed. Investors should note the potential impact on board composition, capital-allocation oversight, and shareholder activism dynamics; the filing attaches the full Cooperation Agreement and press release for details.